A Study of Lepodisiran (LY3819469) in Participants With Normal, Mild, Moderate, or Severe Liver Function

Clinical trial NCT06916078 · COMPLETED

Trial details

NCT number: NCT06916078
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Liver Dysfunction Healthy

Start date: 2025-04-23
Primary completion: 2026-07-13
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.